Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets.

DaSilva, Nicholas A; Barlock, Benjamin J; Guha, Prajna; Ghosh, Chandra C; Trebino, Catherine E; Camberg, Jodi L; Katz, Steven C; Rowley, David C

DaSilva, Nicholas A; Barlock, Benjamin J; Guha, Prajna; Ghosh, Chandra C; Trebino, Catherine E; Camberg, Jodi L; Katz, Steven C; Rowley, David C.

Afiliação

DaSilva NA; University of Rhode Island, Department of Biomedical and Pharmaceutical Sciences, Kingston, RI, USA. ndasilva@uri.edu.
Barlock BJ; University of Rhode Island, Department of Biomedical and Pharmaceutical Sciences, Kingston, RI, USA.
Guha P; Roger Williams Medical Center, Immuno-oncology Institute and Division of Immunotherapy, Department of Medicine, Providence, RI, USA.
Ghosh CC; Boston University School of Medicine, Department of Surgery, Boston, MA, USA.
Trebino CE; Roger Williams Medical Center, Immuno-oncology Institute and Division of Immunotherapy, Department of Medicine, Providence, RI, USA.
Camberg JL; University of Rhode Island, Department of Cell & Molecular Biology, Kingston, RI, USA.
Katz SC; University of Rhode Island, Department of Cell & Molecular Biology, Kingston, RI, USA.
Rowley DC; Roger Williams Medical Center, Immuno-oncology Institute and Division of Immunotherapy, Department of Medicine, Providence, RI, USA.

Cell Death Discov ; 7(1): 232, 2021 Sep 04.

Article em En | MEDLINE | ID: mdl-34482371

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Cell Death Discov Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google